PFIZER INC — Regulatory Filings 2000

Apr 18, 2000

| SECURITIES AND EXCHANGE
COMMISSION Washington, D.C. 20549 | | |
| --- | --- | --- |
| FORM 8-K | | |
| CURRENT REPORT | | |
| PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934 | | |
| Date of report: April 18, 2000 Date of earliest event reported: April
18, 2000 | | |
| PFIZER INC. (Exact name of registrant as
specified in its charter) | | |
| Delaware (State or other jurisdiction of incorporation) | 1-3619 (Commission File Number) | 13-5315170 (I.R.S. Employer Identification
No.) |
| 235 East 42nd Street New York, New York (Address of principal executive
offices) | | 10017 (Zip Code) |
| Registrant's telephone
number, including area code: (212) 573-2323 | | |

Item 5. Other Events Attached and incorporated herein by reference an Exhibit 99.1 is a copy of a press release of Pfizer Inc. dated April 18, 2000 announcing the senior leadership team.

Item 7(c). Exhibits
99.1	Press Release of Pfizer Inc.
dated April 18, 2000 announcing the senior leadership team.

SIGNATURE Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.

	PFIZER INC.
Dated: April 18, 2000	By: /s/ MARGARET M.
FORAN Name: Margaret M. Foran Title: Vice President
- Corporate Governance

Index to Exhibits
99.1	Press Release of Pfizer Inc.
dated April 18, 2000 announcing the senior leadership team.